(Source: ERYTECH Pharma SA) ba57e523-e7e8-45d3-93a7-15952086f562.pdf PRESS RELEASE ERYTECH announces data presentations at the American Society of Hematology 57th Annual Meeting Lyon (France), November 5th 2015 - ERYTECH Pharma (Euronext Paris: ERYP & OTC US: EYRYY), the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia and other malignancies with unmet medical needs, announces the upcoming presentation of three abstracts at the American Society of Hematology (ASH) Annual Meeting taking place in Orlando, Florida, USA from December 5-8, 2015. The poster presentations include: Updated Clinical Activity of GRASPA Versus Native...
↧